ArticlePloS one2026
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).
A M de Jong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.